Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus
2011

Ketamine Reduces Inflammation in Macrophages Stimulated by MRSA

publication Evidence: moderate

Author Information

Author(s): Thomas Spentzas, Rebekah KH Shapley, Carlos Acuna Aguirre, Elizabeth Meals, Lauren Lazar, Mark S Rayburn, Brett S Walker, Keith B English

Primary Institution: University of Tennessee Health Science Center

Hypothesis

Ketamine can suppress macrophage TNF production in response to clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Conclusion

Ketamine inhibits TNF secretion by MRSA-stimulated RAW264.7 macrophages, likely through NMDA receptor antagonism.

Supporting Evidence

  • Ketamine reduced TNF secretion by 18-34% in response to CA-MRSA.
  • Both daptomycin and ketamine showed additive effects in reducing TNF secretion.
  • NMDA receptor antagonists also inhibited TNF secretion similarly to ketamine.

Takeaway

Ketamine helps calm down the immune response in mice when they are infected with a type of bacteria that can cause serious illness.

Methodology

RAW264.7 macrophages were stimulated with CA-MRSA strains in the presence of antibiotics, and TNF secretion was measured after treatment with ketamine and NMDA receptor antagonists.

Limitations

The study was conducted in vitro, and the clinical significance of ketamine's effects in patients with sepsis needs further investigation.

Statistical Information

P-Value

p<0.05

Confidence Interval

95%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2172-12-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication